Finally, we show that targeting small molecules to the condensates formed by AR and, specifically, to the region of sequence that drives its phase separation has an antitumorigenic effect, specific to AR-dependent tumor growth, in an in vivo CRPC model driven by an ‘undruggable’ AR variant. The gene discussed is AR; the disease is neoplasm.